FLSM

Frazier Life Sciences Management Portfolio holdings

AUM $3.34B
1-Year Est. Return 92.56%
This Quarter Est. Return
1 Year Est. Return
+92.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$170M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$66.7M
2
+$28.7M
3
+$23.4M
4
ANTX icon
AN2 Therapeutics
ANTX
+$22.3M
5
BBIO icon
BridgeBio Pharma
BBIO
+$19.4M

Top Sells

1
+$167M
2
+$45.1M
3
+$15.2M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$10.2M
5
IMVT icon
Immunovant
IMVT
+$5.69M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$951K 0.06%
500,333
52
– –
-300,000
53
– –
-265,511
54
– –
-100,430
55
– –
-4,345,559
1 2
3